Innovation at the heart of Medikemos
Innovation is part of Medikemos’ DNA. Since its creation, the clinic has not simply applied existing techniques. It has sought to understand them, refine them and move them forward.

Our Research and Development department works continuously to improve knowledge, technologies and protocols used in hair health, with one constant objective: to offer patients more precise, safer and longer-lasting solutions.

Why research matters in hair health
Hair restoration is both a medical and technical field where the quality of a result often depends on invisible details: the precision of an instrument, the preservation of a graft, the accuracy of a diagnosis.

Investing in research means validating what truly works, moving beyond marketing promises and helping the discipline progress on solid foundations.

Our areas of development
Artificial intelligence and enhanced diagnosis
AI opens major perspectives for hair diagnosis by analyzing scalp images and objectively measuring density, hair diameter and miniaturization.

Dedicated instrument design
A key part of our research focuses on the tools themselves, including instruments designed to refine FUE, protect grafts and improve precision.

Regenerative medicine
Beyond PRP, regenerative medicine is an evolving field that we follow with rigor, only considering approaches when their value and safety are sufficiently established.

Optimization of treatment protocols
Our work aims to maximize graft survival, reduce tissue trauma and improve pre- and post-operative care.

Clinical data analysis
By documenting and analyzing outcomes and follow-up, we aim to identify what truly makes a difference over time.

Development of new products
The Hair Care and IV Care collections extend this research through formulations designed around real needs observed in the clinic.

Connected to the international hair restoration community
Through the World FUE Institute, of which Dr. Lupanzula is a founding member and served as president from 2024 to 2026, Medikemos contributes to the development of new approaches and knowledge sharing at international congresses.

What research validates, Medikemos Academy transmits. Our advances feed directly into practitioner training and help raise quality standards in the field.

Responsible innovation
Innovation in medicine requires one essential rule: never place novelty ahead of the patient.

Every evolution is evaluated before being proposed, in accordance with the principle primum non nocere – first, do no harm. At Medikemos, innovation is not a marketing argument. It is a responsibility in the service of long-lasting results.

In brief